AI Science Tracker
EN

Melanoma analyses link mutation subtypes to distinct tumor immune signatures

Affiliation not stated in the reviewed material · 27 Jun 2026 · medicine

Discovery

Melanoma analyses link mutation subtypes to distinct tumor immune signatures

Source check: Source checked. Not independent scientific confirmation.

Finding: Cross-cohort AI analysis linked melanoma mutation subtypes to distinct immune landscapes and implicated CCNE1; cell-line knockdown provided functional support.

Technology: Machine learning survival models, including regularized regression and tree-based methods

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
The study compared learned survival models to identify an inflammatory signature and nominate CCNE1 from melanoma datasets.
Test and result
Four expression cohorts plus cell-line functional validation; retrospective data and in-vitro support do not establish treatment efficacy.
Limitation / still unknown
The four-cohort analyses and cell-line knockdown do not establish treatment efficacy in patients.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13309799/ · https://pmc.ncbi.nlm.nih.gov/articles/PMC13309799/#methods · https://pmc.ncbi.nlm.nih.gov/articles/PMC13309799/#results

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.